Syndax Pharmaceuticals Inc — Director's Dealing 2021

Feb 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Syndax Pharmaceuticals Inc (SNDX)
CIK: 0001395937
Period of Report: 2021-02-03

Reporting Person: Karydas Daphne (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-03	Stock Option (Right to Buy)	$21.36	A	95000.00	Acquired	2031-02-03	Common Stock (95000.00)	Direct

Footnotes

F1: 1/48th of the shares subject to the option shall vest monthly over a four-year period.